MDI
Middle Island Resources Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-18.26%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Middle Island Resources Ltd. is an exploration company, which engages in the business of identifying, acquiring, and exploring mineral assets. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-16. The firm is focused on copper and gold minerals. Its 100% owned Barkly Copper-Gold Super Project comprises approximately 16 exploration licenses (13 granted and three applications) cover an aggregate of 6,918 square kilometers (km2). The Barkly tenements extend from outcropping areas near Tennant Creek and the interpreted eastward extensions of prospective Proterozoic stratigraphy that includes the East Tennant Ridge and Burnette Downs Rift corridor beneath shallow to moderate depth Georgina Basin cover. Its prospects include Crosswinds, Eiger and Zermatt. The firm's subsidiary is Barkly Operations Pty Ltd.
📈 Performance
Price History
-95.40%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.02
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in MDI
1
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
55 weeks
💵 Average investment amount
$700
⏰ Last time a customer invested in MDI
379 days
MDI investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
100%
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
100%
Male
Pearlers who invest in MDI also invest in...
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
🙌 Performance (5Yr p.a)
12.98%
📊 Share price
$14.81 AUD
🇦🇺 EX AUSTRALIA
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
4.29%
📊 Share price
$90.79 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.27%
📊 Share price
$126.64 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
🙌 Performance (5Yr p.a)
16.79%
📊 Share price
$413.38 AUD
🇺🇸 UNITED STATES
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.57%
📊 Share price
$66.42 AUD
⛳️ DIVERSIFIED
🕊️ SOCIALLY AWARE
🌏 GLOBAL
Want more shares? Try these...
MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm's segments include Australia, the United States, the United Kingdom and Asia Operations. The firm's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The firm's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
🙌 Performance (5Yr p.a)
155.56%
📊 Share price
$0.40 AUD
🩺 HEALTH CARE
Mindax Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-12-08. The firm's segments include Gold and Iron Ore. The Gold segment includes Meekatharra and Mt Lucky Projects. The Iron Ore segment comprises the Mt Forrest Project. The Meekatharra Gold Project (Meekatharra North), tenement E51/1705, lies within the Murchison Gold Field of Western Australia, approximately 40 kilometers (km) north of Meekatharra and two km south of the Andy Well Gold Mine. The Mt Lucky Gold Project, tenement E38/3336, lies within the Mt Margaret Mineral Field of the north-eastern Goldfields of Western Australia (Laverton Greenstone Belt), approximately seven km east of the Granny Smith gold mine (plant capacity 3.5 million tons per annum) and 12 km southeast of Laverton. The Mt Forrest magnetite iron ore project is operated through a joint venture. The company is exploring a regional infrastructure concept centered around its Mt Forrest project, and other surrounding or neighboring projects.
🙌 Performance (5Yr p.a)
313.33%
📊 Share price
$0.05 AUD
⛏️ MINING
Mercury NZ Ltd. engages in the generation and distribution of electricity from hydro, geothermal, and gas. The company is headquartered in Tauranga, Bay Of Plenty and currently employs 1,512 full-time employees. The company went IPO on 2013-05-10. The firm is also a retailer of electricity, gas, broadband and mobile services to residential and small to medium-sized business customers. The firm is operating through the segments: Generation/Wholesale, Retail, and Other. The generation/wholesale market segment encompasses activity associated with the electricity production, electricity trading, generation development activities. The company also includes revenue from the sale of electricity, to both commercial & industrial customers. The retail market segment encompasses activity associated with sale of electricity, gas, telecommunication products/services and other related products and services to customers in New Zealand through Mercury and Trustpower brands. The Other segment represents corporate support services. The Company’s products include electricity, gas, broadband, and mobile.
🙌 Performance (5Yr p.a)
3.31%
📊 Share price
$5.42 AUD
🔋 UTILITIES
Medlab Clinical Ltd. is a biotechnology company, which engages in the development of nutraceutical products for chronic diseases and mental health conditions. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. The firm is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.
🙌 Performance (5Yr p.a)
-18.09%
📊 Share price
$6.60 AUD
🧬 BIOTECHNOLOGY